İstanbul escort bayan sivas escort samsun escort bayan sakarya escort Muğla escort Mersin escort Escort malatya Escort konya Kocaeli Escort Kayseri Escort izmir escort bayan hatay bayan escort antep Escort bayan eskişehir escort bayan erzurum escort bayan elazığ escort diyarbakır escort escort bayan Çanakkale Bursa Escort bayan Balıkesir escort aydın Escort Antalya Escort ankara bayan escort Adana Escort bayan

58.9 F
San Diego
Thursday, May 30, 2024
-Advertisement-

MicroIslet Files for Chapter 11

MicroIslet, a publicly traded San Diego biotech engaged in stem cell therapies to treat diabetes, said Nov. 10 it filed for Chapter 11 bankruptcy protection.

The company said it plans to continue operating the business “without interruption” as the management team leads its restructuring plan.

“During the past 16 months we believe we have made substantial progress toward the goal of getting the company’s lead product, MicroIslet-PTM, ready for human clinical trials,” said Michael Andrews, CEO of MicroIslet, in a statement. “Unfortunately, during that period of time capital markets have not responded to these advances, and we have not been able to secure significant funding as a public company.”

Andrews said the company aimed to simplify its capital structure to enable the filing of an investigational new drug application with the FDA, and to emerge from bankruptcy as a private company.

MicroIslet also said it filed a series of motions with the bankruptcy court to assure the continuity and stability of the business, including the payment of wages to employees and vendors.

, Heather Chambers

-Advertisement-

Featured Articles

Hair Today, Hair Tomorrow

Oberon Eyes Europe for Renewable DME

Leaders of Influence in Law 2024

-Advertisement-
-Advertisement-

Related Articles

-Advertisement-
-Advertisement-
-Advertisement-